id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2365-0005,FDA,FDA-2020-E-2365,Determination of Regulatory Review Period for Purposes of Patent Extension; NURTEC ODT,Notice,Determinations,2022-09-23T04:00:00Z,2022,9,2022-09-23T04:00:00Z,2022-11-23T04:59:59Z,2022-09-23T14:07:09Z,2022-20634,0,0,090000648535bafa
FDA-2020-E-2365-0004,FDA,FDA-2020-E-2365,"Letter from FDA CDER to U.S, Patent and Trademark Office",Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T19:45:17Z,,0,0,09000064852d06c2